AGK and cancer: Activated BRAF can promote oncogenesis by activating downstream MEK‐ERK signaling, and the AGK‐BRAF fusion has been identified previously in lung and other cancer types.30, 31, 32 This is a compelling finding in that if this AGK‐BRAF fusion had been detected during clinical care, the result may have informed clinical management with consideration of BRAF targeted therapy.